It is probably no coincidence that the Covid-19 epidemic is severe in Guadeloupe, Martinique, Guyana or even on the island of Reunion. In reality, these
Author: admin000biet
Professors Debré and Even banned from practicing medicine
The Order of Physicians sanctioned Professors Debré and Even for their book “Guide to 4,000 useful, useless or dangerous drugs”. They were banned from practicing
Hospitals: “Mexico pays these caregivers better than France”, says Jordan Bardella (RN)
France fears a possible second wave of coronavirus. “If there is to be a second wave and especially at the start of the school year,
Carcinogenic meat: these countries that see red after WHO warnings
The revelations of the World Health Organization on the increased risks of having cancer for heavy consumers of cold cuts and red meat, Monday, October
Farmers worried about meat prices
Following the classification of red meat and charcuterie as carcinogenic products, French breeders remain concerned about meat prices. This Tuesday evening, they were received by
Covid-19: the worrying situation in the Bouches-du-Rhône
With 900 positive cases per 100,000 inhabitants, the town of Arles, in the Bouches-du-Rhône, is one of the cities in France where the Covid-19 circulates
Conflict of interest: mass resignations at Afssaps
It’s a real thunderbolt: 40 of the 43 experts of the working group on anti-infectives who advised the French Agency for Health Security and
Red meat: which European countries are the most addicted to it?
Faced with the risk of developing cancer, Europeans are not all equal. While the International Agency for Research on Cancer (IARC), which depends directly on
Cancer: meat manufacturers have trouble digesting WHO accusations
General outcry among meat professionals, from France to the United States via Brazil. The industrialists of the major producing countries are responding with arguments, Monday,
90,000 euros to treat hepatitis C: is this drug too expensive?
The new hepatitis C drug is very effective, but also very expensive. Sofosbuvir, a new treatment lasting 3 to 6 months, is marketed by the
